105 related articles for article (PubMed ID: 18254285)
1. [Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases].
Jmal A; Ghanem A; Boussen H; Gara Y; Abaza H; Gara S; Harzallah L; Ladgham A; Guemira F
Tunis Med; 2007 Aug; 85(8):651-4. PubMed ID: 18254285
[TBL] [Abstract][Full Text] [Related]
2. [Contribution of serum Cyfra 21-1 in nasopharyngeal carcinoma in Tunisia].
Jmal A; Boussen H; Abdennebi M; Gara S; Harzallah L; Gritli S; Ladgham A; Guemira F; Ghanem A
Bull Cancer; 2004 Apr; 91(4):369-72. PubMed ID: 15242321
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
[TBL] [Abstract][Full Text] [Related]
4. [Serum lactate dehydrogenase and its isoenzymes in nasopharyngeal carcinoma in Tunisia].
Jmal A; Abdennebi M; Boussen H; Abaza H; Gara S; Bendjemana K; Harzallah L; Guemira F; Ghanem A
Tunis Med; 2005 Apr; 83(4):218-20. PubMed ID: 15966667
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis.
Makis AC; Galanakis E; Hatzimichael EC; Papadopoulou ZL; Siamopoulou A; Bourantas KL
J Infect; 2005 Oct; 51(3):206-10. PubMed ID: 16230217
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
12. Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
Hui EP; Sung FL; Yu BK; Wong CS; Ma BB; Lin X; Chan A; Wong WL; Chan AT
Clin Cancer Res; 2008 Nov; 14(21):7080-7. PubMed ID: 18981006
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
Hsu MM; Chen YJ; Chang YL; Ko JY; Sheen TS
Asian Pac J Allergy Immunol; 1995 Jun; 13(1):1-4. PubMed ID: 7488337
[TBL] [Abstract][Full Text] [Related]
14. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma.
Yadav M
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):123-6. PubMed ID: 1948253
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble interleukin-2 receptor alpha in systemic lupus erythematosus.
El-Shafey EM; El-Nagar GF; El-Bendary AS; Sabry AA; Selim AG
Iran J Kidney Dis; 2008 Apr; 2(2):80-5. PubMed ID: 19377213
[TBL] [Abstract][Full Text] [Related]
17. Serum level of soluble interleukin-2 receptor alpha as a predictor of treatment response in brucellosis.
Kahbazi M; Rezapour H; Jafari F; Arjomandzadegan M; Sofian M; Zarinfar N; Sarmadiayan H; Najmi AR
J Ayub Med Coll Abbottabad; 2012; 24(2):44-6. PubMed ID: 24397050
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells.
Tsai MH; Chiou SH; Chow KC
Int J Oncol; 2001 Nov; 19(5):1049-55. PubMed ID: 11605008
[TBL] [Abstract][Full Text] [Related]
19. [Serum acute phase proteins in nasopharyngeal carcinoma and laryngeal cancers].
Chen P
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(3):174-6, 190. PubMed ID: 2484505
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]